Anthracycline cardiotoxicity and its role in the development of heart failure
https://doi.org/10.29001/2073-8552-2021-36-4-164-167
Abstract
Anthracycline antibiotics are an important group of widely used and highly eff ective antitumor drugs. However, the cardiotoxicity of anthracyclines included in the polychemotherapy regimens results in the development of cardiovascular diseases both in the early and late rehabilitation period. The article presents a clinical case demonstrating the long-term consequences of highdose polychemotherapy with the onset of heart failure and coronary artery disease.
About the Authors
N. G. Lozhkina
Novosibirsk State Medical University
Russian Federation
Russian Federation
Dr. Sci. (Med.), Professor, Department of Faculty Therapy; Cardiologist and Curator, Department for Treatment of Patients with Acute Coronary Syndrome, Regional Vascular Center No. 1
52, Krasny ave., Novosibirsk, 630091, Russian Federation
A. N. Spiridonov
Institute of Internal and Preventive Medicine, Federal Research Center Institute of Cytology and Genetics
Russian Federation
Russian Federation
Resident Physician in Cardiology
175/1, B. Bogatkov str., Novosibirsk, 630089, Russian Federation
References
1. Tereshchenko S.N., Zhirov I.V. Chronic heart failure: New challenges and new perspectives. Therapeutic Archive. 2017;89(9):4–9 (In Russ.). DOI: 10.17116/terarkh20178994-9.
2. Ponikowski P., Voors A.A., Anker S.D., Bueno H., Cleland J.G.F., Coats A.J.S. et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2016. Russian Journal Cardiology. 2017;1:7–81 (In Russ.). DOI: 10.15829/1560-4071-2017-1-7-81.
3. André M., Mounier N., Leleu X., Sonet A., Brice P., Henry-Amar M. et al. Second cancers and late toxicities after treatment of aggressive non-Hodgkin lymphoma with the ACVBP regimen: A GELA cohort study on 2837 patients. Blood. 2004;103(4):1222–1228. DOI: 10.1182/blood-2003-04-1124.
4. Divakaran S., Biery D.W., Berman A.N., Singh A., Hainer J., Wu W.Y. et al. Long-term outcomes following myocardial infarction in young adult survivors of Hodgkin lymphoma: The YOUNG-MI registry. JASS CardioOncology. 2021;3(2):319–321. DOI: 10.1016/j.jaccao.2021.04.001.
5. Dorokhina E.I. Long-term results and toxicity of high-dose chemotherapy in adult patients with diffuse large B-cell lymphoma according to the modified NHL-BFM-90 program: Abstr. Dis. … Cand. Sci. Med. Мoscow; 2016:15 (In Russ.).
6. Tursunova N.V., Klinnikova M.G., Babenko O.A., Lushnikova E.L. Molecular mechanisms of correction of cardiotoxic effects of anthracyclines by cardioprotectors. Modern Problems of Science and Education. 2020;4 (In Russ.). URL: https://science-education.ru/ru/article/view?id=30035 (available: 28.08.2021).
Review
For citations:
Lozhkina N.G., Spiridonov A.N. Anthracycline cardiotoxicity and its role in the development of heart failure. Siberian Journal of Clinical and Experimental Medicine. 2021;36(4):164-167. (In Russ.) https://doi.org/10.29001/2073-8552-2021-36-4-164-167
Views:
1096
.png)
Email this article 